Pacific Biosciences of California | ARS:年度報告
Pacific Biosciences of California | DEFA14A:其他
Pacific Biosciences of California | DEF 14A:股東委託書決議
Pacific Biosciences of California | 8-K:PacBio 公佈 2024 年第一季度初步收入和更新 2024 年收入指引宣佈計劃將 2024 年第一季度年化運營費用運行率降低 5,000 萬至 7,500 萬美元的 2024 年第一季度業績電話會議定於 2024 年 5 月 9 日舉行
Pacific Biosciences of California | PRE 14A:並購重組委托聲明
Pacific Biosciences of California | POSASR:註冊聲明修正稿
Pacific Biosciences of California | POSASR:註冊聲明修正稿
Pacific Biosciences of California | POSASR:註冊聲明修正稿
Pacific Biosciences of California | 4:持股變動聲明-董事 ORDONEZ KATHY
Pacific Biosciences of California | 4:持股變動聲明-董事 Meline David W
Pacific Biosciences of California | 4:持股變動聲明-高管 Farmer Michele
Pacific Biosciences of California | 4:持股變動聲明-高管 Van Oene Mark
Pacific Biosciences of California | 4:持股變動聲明-高管 Kim Susan G.
Pacific Biosciences of California | 4:持股變動聲明-高管 HENRY CHRISTIAN O
Pacific Biosciences of California | 4:持股變動聲明-董事 MOHR MARSHALL
Pacific Biosciences of California | 144:擬議出售證券
Pacific Biosciences of California | 144:擬議出售證券
Pacific Biosciences of California | 144:擬議出售證券
Pacific Biosciences of California | S-8:員工福利計劃證券登記
Pacific Biosciences of California | 10-K:年度報表
暫無數據